In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Inozyme Pharma (INZY – Research Report). The company’s shares opened today at $1.14. Effectively assess a stock ...

Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...

(PRNewsfoto/Sun Pharmaceutical Industries Inc., USA (Sun Pharma)) Checkpoint is a Nasdaq-listed commercial-stage company focused on developing novel treatments for patients with solid tumor cancers.

The deal is in line with Sun Pharma's active push in recent years to expand its oncology and immunotherapy portfolio through several acquisitions and collaborations. Last year, it signed ...

Hampton was appointed by the Justice Department in 2019 to represent the financial interests of victims in the Purdue Pharma bankruptcy case. For two years, he served on a committee of creditors.

aTyr Pharma (ATYR) announced the outcome of a fourth, pre-planned interim safety analysis conducted by an independent data and safety monitoring board for the ongoing Phase 3 EFZO-FIT study of the ...

The health of America is in jeopardy. Doctors do not have access to the full safety and effectiveness data for the treatments we rely upon. Pharmaceutical companies control and hide information ...

Pharma products are generally supposed to be exempt from tariffs, according to a 1994 World Trade Organisation (WTO) agreement, devised to ensure better access to medicines globally. However ...

PETALING JAYA: ACE Market-listed Kanger International Bhd has entered into a memorandum of understanding (MoU) with Zuellig Pharma Sdn Bhd for Covid-19 vaccine distribution in Malaysia. Zuellig ...

TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...

The coming years will be more about practical uses of AI, as businesses ensure they get their money’s worth by using AI to address specific use cases, not least of which will be seen in the pharma ...